risks of compounded tirzepatide vs. Zepbound – Forbes Health Lilly Says Compounded Tirzepatide With

Obesity affects more than 40% of U.S

Methods In this double-blind trial, we enrolled 1961 adults with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or greater (27 in persons with 1 weight-related coexisting condition), who did not have diabetes, and randomly assigned them, in a 2:1 ratio, to 68 weeks of treatment with once-weekly subcutaneous semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention

L.HallM

Heres what you may experience and what experts recommend you do to reduce your risk and feel better

Important Note : The FDA doesn't approve over-the-counter skin lightening products as safe or effective

Some patients may respond to a lower dose or prefer slower dose escalation because of nausea, constipation, or other gastrointestinal symptoms